Access cutting-edge moderate to severe atopic dermatitis treatment through this clinical trial at a research site in Arkansas City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Arkansas City location
Preparing your pre-screening questions…
Access moderate to severe atopic dermatitis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related moderate to severe atopic dermatitis treatment provided free
Check if you qualify for this moderate to severe atopic dermatitis clinical trial in Arkansas City, AR
No-Cost Study Care
Local to Arkansas City
Convenient for AR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to evaluate the study drug, SYX-5219, in a multi-part First-in-Human (FiH) study to be conducted in healthy volunteers and participants with Atopic Dermatitis (AD). The objectives of this study are to determine the safety, tolerability and levels of SYX-5219 in the blood and urine when SYX-5219 is given in each part of the study (SAD, MAD, Food Effect and Participants with AD). The study will be split into up to 3 parts as follows: * Part 1 - Single Ascending Dose (SAD) and Food Effect in healthy volunteers * Part 2 - Multiple Ascending Dose (MAD) in healthy volunteers * Part 3 - Multiple Dose in Participants with AD - enrolling up to 45 males and females with a confirmed diagnosis of AD of at least 6 months, evaluating multiple dose administrations of SYX-5219 or placebo daily over a period of 42 days.
Sponsor: Sitryx Therapeutics Ltd
Yes, this clinical trial (NCT07558668) has an active research site in Arkansas City, AR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for moderate to severe atopic dermatitis treatment options in Arkansas City, AR, this clinical trial (NCT07558668) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Arkansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced moderate to severe atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all moderate to severe atopic dermatitis clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Arkansas City — not just this study.
Browse Rheumatoid Arthritis Trials in Arkansas City →